Emerging Stocks Down Under 29 September 2020: Recce Pharmaceuticals, Energy One, 9Spokes
Emerging Stocks Down Under Edition #2
Recce Pharmaceuticals: Antibiotic resistance may have met its match
Today in Emerging Stocks Down Under it’s been a spectacular re-rating. The drug developer Recce Pharmaceuticals could be had for just 23 cents a share back on 24 March 2020. It’s since gone up about sevenfold, thanks to a succession of favourable announcements related to Recce’s lead compound, a fast acting, broad-spectrum antibiotic called Recce 327.
Also in today's edition, a look at energy trading and logistics software developer Energy One and application marketplace 9Spokes.
Get access to all editions through a 2-week FREE TRIAL. No charge on sign up.
Click here to read the previous edition of Emerging Stocks Down Under published 22 September 2020